Literature DB >> 12528939

How does H. pylori infection cause gastric cancer?

Kenneth E L McColl1, Emad El-Omar.   

Abstract

H. pylori is now recognised to be an important co-factor in the aetiology of non-cardia gastric cancer of both the diffuse and intestinal histological type. The latter type develops via a complex multistage and multifactorial process. The fist stage involves progression from superficial gastritis to atrophic pangastritis with intestinal metaplasia and associated hypochlorhydria. This gastric phenotype may then progress to dysplasia and cancer. Many co-factors are involved in this progression including the strain of H. pylori, host genetic factors, such as interleukin-1 polymorphisms and gender, plus environmental factors such as smoking and diet. Intestinal colonisation with helminthic infection may retard the progression by altering the immune and inflammatory response to H. pylori and colonisation of the achlorhydric stomach with nitrosating bacteria may promote progression to cancer. H. pylori appears to be an obligatory co-factor in the aetiology of most gastric cancers. Consequently, prevention of the infection or its eradication in early life should reduce the incidence of this common and usually fatal tumour.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12528939     DOI: 10.2302/kjm.51.supplement2_53

Source DB:  PubMed          Journal:  Keio J Med        ISSN: 0022-9717


  8 in total

1.  Association of specific haplotype of TNFalpha with Helicobacter pylori-mediated duodenal ulcer in eastern Indian population.

Authors:  Meenakshi Chakravorty; Dipanjana Datta De; Abhijit Choudhury; Amal Santra; Susanta Roychoudhury
Journal:  J Genet       Date:  2008-12       Impact factor: 1.166

2.  Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.

Authors:  Svein Hansen; Stein Emil Vollset; Mohammad H Derakhshan; Valerie Fyfe; Kjetil K Melby; Steinar Aase; Egil Jellum; Kenneth E L McColl
Journal:  Gut       Date:  2007-02-22       Impact factor: 23.059

3.  Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.

Authors:  Ramin Shakeri; Reza Malekzadeh; Dariush Nasrollahzadeh; Michael Pawlita; Michael Pawilta; Gwen Murphy; Farhad Islami; Masoud Sotoudeh; Angelika Michel; Arash Etemadi; Tim Waterboer; Hossein Poustchi; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Farin Kamangar; Christian C Abnet
Journal:  Cancer Res       Date:  2015-09-17       Impact factor: 12.701

4.  Distribution of cagG gene in Helicobacter pylori isolates from Chinese patients with different gastroduodenal diseases and its clinical and pathological significance.

Authors:  Can Xu; Zhao-Shen Li; Zhen-Xing Tu; Guo-Ming Xu; Yan-Fang Gong; Xiao-Hua Man
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

5.  Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer.

Authors:  Masoud Sotoudeh; Mohammad H Derakhshan; Behnoosh Abedi-Ardakani; Mehdi Nouraie; Abass Yazdanbod; Seyyed Mohammad Tavangar; Javad Mikaeli; Shahin Merat; Reza Malekzadeh
Journal:  Dig Dis Sci       Date:  2007-05-10       Impact factor: 3.199

Review 6.  Helicobacter pylori and gastric cancer: a state of the art review.

Authors:  Sauid Ishaq; Lois Nunn
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

7.  Molecular docking, pharmacophore based virtual screening and molecular dynamics studies towards the identification of potential leads for the management of H. pylori.

Authors:  Manoj G Damale; Rajesh B Patil; Siddique Akber Ansari; Hamad M Alkahtani; Abdulrahman A Almehizia; Devanand B Shinde; Rohidas Arote; Jaiprakash Sangshetti
Journal:  RSC Adv       Date:  2019-08-21       Impact factor: 4.036

8.  Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis.

Authors:  Alireza Sadjadi; Abbas Yazdanbod; Yeong Yeh Lee; Majid Boreiri; Fatemeh Samadi; Behrooz Z Alizadeh; Farhad Islami; Valerie Fyfe; Masoud Babaei; Mohammad J Namazi; James J Going; Masoud Sotoudeh; Geertruida H de Bock; Reza Malekzadeh; Mohammad H Derakhshan
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.